SLC7A1 and neoplasm: Our previous studies have shown that SLC7A1 is highly expressed in EOC cells and is involved in tumor progression, platinum resistance, and amino acid metabolic remodeling in EOC, and is associated with poor progression‐free survival (PFS) in OC patients.20